SCHEMBL20069992

SCHEMBL20069992

COc1ccc(CN2CC3CC2CN3)cn1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.60
CHRNA4 P43681 6/20 0.60
TLR7 Q9NYK1 4/20 0.46
LTA4H P09960 1/20 0.46
TRPV6 Q9H1D0 1/20 0.44
FLT3 P36888 1/20 0.43
TYRO3 Q06418 1/20 0.43
MERTK Q12866 1/20 0.43
GAS6 Q14393 1/20 0.43
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
PDE5A O76074 1/20 0.39
P2RX7 Q99572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20070838 1.00 CHRNB2 (0.60) CHRNB2CHRNA4TLR7LTA4HTRPV6
SCHEMBL20069989 1.00 CHRNB2 (0.60) CHRNB2CHRNA4TLR7LTA4HTRPV6
SCHEMBL22031253 1.00 CHRNB2 (0.60) CHRNB2CHRNA4TLR7LTA4HTRPV6
Hydrochloric Acid SCHEMBL31458823 0.99 CHRNB2 (0.59) CHRNB2CHRNA4TLR7LTA4HTRPV6
Hydrochloric Acid SCHEMBL20136938 0.99 CHRNB2 (0.59) CHRNB2CHRNA4TLR7LTA4HTRPV6
Trifluoroacetic Acid SCHEMBL20136638 0.89 CHRNB2 (0.53) CHRNB2CHRNA4TLR7LTA4HTRPV6
SCHEMBL20255464 0.83 CHRNB2 (0.58) CHRNB2CHRNA4TLR7LTA4HFLT3
SCHEMBL28921727 0.81 CHRNB2 (0.58) CHRNB2CHRNA4TLR7LTA4HFLT3
SCHEMBL20249498 0.80 LTA4H (0.43) CHRNB2CHRNA4TLR7LTA4HFLT3
SCHEMBL20160368 0.78 RET (0.47) CHRNB2CHRNA4TLR7TRPV6KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071447-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed